Total Payments
$21,121
2024 Payments
$2,953
Companies
81
Transactions
1,298
Medicare Patients
2,227
Medicare Billing
$269,801
Payment Breakdown by Category
Food & Beverage$20,558 (97.3%)
Education$328.30 (1.6%)
Other$234.21 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,558 | 1,273 | 97.3% |
| Education | $328.30 | 10 | 1.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $234.21 | 15 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $3,351 | 214 | $0 (2024) |
| UCB, Inc. | $1,068 | 49 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,015 | 80 | $0 (2024) |
| ABBVIE INC. | $995.18 | 57 | $0 (2024) |
| Genentech USA, Inc. | $981.33 | 63 | $0 (2024) |
| EMD Serono, Inc. | $963.79 | 98 | $0 (2024) |
| GENZYME CORPORATION | $871.76 | 48 | $0 (2022) |
| SK Life Science, Inc. | $858.14 | 57 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $744.75 | 49 | $0 (2024) |
| Biogen, Inc. | $641.63 | 50 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,953 | 155 | UCB, Inc. ($445.46) |
| 2023 | $3,239 | 172 | UCB, Inc. ($366.09) |
| 2022 | $3,368 | 189 | Abbott Laboratories ($269.53) |
| 2021 | $2,927 | 186 | Teva Pharmaceuticals USA, Inc. ($577.30) |
| 2020 | $1,997 | 124 | Teva Pharmaceuticals USA, Inc. ($308.93) |
| 2019 | $2,142 | 142 | Teva Pharmaceuticals USA, Inc. ($616.57) |
| 2018 | $2,705 | 196 | Teva Pharmaceuticals USA, Inc. ($1,043) |
| 2017 | $1,790 | 134 | Teva Pharmaceuticals USA, Inc. ($292.68) |
All Payment Transactions
1,298 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Neuromodulation | ||||||
| 12/23/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $31.17 | General |
| Category: Neurology | ||||||
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: PAIN | ||||||
| 12/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/17/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/09/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.25 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Immunology | ||||||
| 12/04/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Neurology | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: PAIN | ||||||
| 12/02/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $15.45 | General |
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: PAIN | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.66 | General |
| Category: Neurology | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: PAIN | ||||||
| 11/13/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Rare Disease | ||||||
| 11/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Neuromodulation | ||||||
| 11/05/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 616 | 805 | $214,384 | $76,846 |
| 2022 | 12 | 517 | 669 | $165,464 | $61,992 |
| 2021 | 13 | 593 | 776 | $198,208 | $80,639 |
| 2020 | 9 | 501 | 628 | $136,803 | $50,324 |
Total Patients
2,227
Total Services
2,878
Medicare Billing
$269,801
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 193 | 290 | $74,314 | $25,840 | 34.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 67 | 86 | $30,992 | $11,568 | 37.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 55 | 56 | $14,690 | $5,997 | 40.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 38 | $13,684 | $5,296 | 38.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 32 | 67 | $12,364 | $4,925 | 39.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 41 | $9,372 | $4,011 | 42.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $11,768 | $3,939 | 33.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $10,170 | $3,871 | 38.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 50 | $7,964 | $3,156 | 39.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 20 | 20 | $8,220 | $3,069 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 51 | $9,298 | $3,050 | 32.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 44 | 48 | $11,548 | $2,123 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 184 | 272 | $68,256 | $26,026 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 134 | $23,648 | $7,904 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $12,528 | $4,596 | 36.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 21 | 43 | $8,798 | $3,679 | 41.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 29 | 29 | $7,880 | $3,229 | 41.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 22 | $7,574 | $3,173 | 41.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $9,286 | $3,108 | 33.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 34 | $7,044 | $2,788 | 39.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $5,962 | $2,447 | 41.0% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 11 | 11 | $4,144 | $1,678 | 40.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 25 | $3,550 | $1,461 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 14 | 14 | $4,756 | $1,337 | 28.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 11 | 12 | $2,038 | $566.88 | 27.8% |
About Dr. Ankit Patel, M.D
Dr. Ankit Patel, M.D is a Neurology healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1083979322.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ankit Patel, M.D has received a total of $21,121 in payments from pharmaceutical and medical device companies, with $2,953 received in 2024. These payments were reported across 1,298 transactions from 81 companies. The most common payment nature is "Food and Beverage" ($20,558).
As a Medicare-enrolled provider, Patel has provided services to 2,227 Medicare beneficiaries, totaling 2,878 services with total Medicare billing of $269,801. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Katy, TX
- Active Since 07/12/2012
- Last Updated 09/19/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1083979322
Products in Payments
- AJOVY (Drug) $1,061
- AJOVY (Biological) $983.08
- NUPLAZID (Drug) $744.75
- COPAXONE (Drug) $729.13
- KESIMPTA (Drug) $727.97
- OCREVUS (Biological) $727.01
- AUBAGIO (Drug) $702.78
- INFINITY (Device) $579.32
- APTIOM (Drug) $554.12
- NURTEC ODT (Drug) $490.91
- UBRELVY (Drug) $430.67
- ACTHAR (Biological) $364.46
- Gamunex-C (Biological) $360.66
- QULIPTA (Drug) $352.11
- Rebif (Biological) $347.68
- TECFIDERA (Drug) $346.65
- VALTOCO (Drug) $323.63
- GAMMAGARD (Biological) $314.86
- EMGALITY (Drug) $307.91
- ULTOMIRIS (Biological) $302.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Katy
Dr. Jose Diaz, M.d, M.D
Neurology — Payments: $105,577
Neurology $105,577
Sevak Ohanian, Md, MD
Neurology — Payments: $20,220
Neurology $20,220
Dr. Sadia Yasser, M.d, M.D
Neurology — Payments: $5,365
Neurology $5,365
Shima Bozorgui, Md, Mph, MD, MPH
Neurology — Payments: $155.34
Neurology $155.34
Ibrahim Noorbhai
Neurology — Payments: $40.16
Neurology $40.16
Hannah Sutherland, Pt, Dpt, PT, DPT
Neurology
Neurology